Liver Cirrhosis and Diabetes Mellitus Are Risk Factors for Staphylococcus aureus Infection in Patients with Healthcare-Associated or Hospital-Acquired Pneumonia
Table 1
Clinical characteristics between presence and absence of S. aureus infection in HCAP or HAP patients with severe sepsis.
S. aureus ()
No S. aureus ()
value
Age, years
73.7 14.4
73.9 13.0
0.938
APACHE II score
26.0 6.7
27.0 7.8
0.477
Sex, number (%)
0.916
Male
43 (68.3)
151 (68.9)
Female
20 (31.7)
68 (31.1)
History, number (%)
Prior antibiotic use
20 (31.7)
64 (29.2)
0.700
Intravenous drug use
0 (0.0)
0 (0.0)
COPD
9 (14.3)
47 (21.5)
0.208
CHF
10 (15.9)
17 (7.8)
0.054
Hypertension
26 (41.3)
90 (41.1)
0.980
Liver cirrhosis
11 (17.5)
14 (6.4)
0.006
Hemodialysis
4 (6.3)
20 (9.1)
0.485
Diabetes mellitus
27 (42.9)
62 (28.3)
0.029
Adverse events, number (%)
RF with intubation and MV
63 (100.0)
219 (100.0)
GI bleeding
8 (12.7)
33 (15.1)
0.638
Shock
31 (49.2)
100 (45.7)
0.619
New arrhythmia
4 (6.3)
13 (5.9)
1.000
Acute renal failure
27 (42.9)
92 (42.0)
0.904
Jaundice
7 (11.1)
17 (7.8)
0.401
Thrombocytopenia
23 (36.5)
83 (37.9)
0.841
30-day mortality, number (%)
25 (39.7)
100 (45.7)
0.400
S. aureus: Staphylococcus aureus; HCAP: healthcare-associated pneumonia; HAP: hospital-acquired pneumonia; APACHE: Acute Physiology and Chronic Health Evaluation; COPD: chronic obstructive pulmonary disease; CHF: congestive heart failure; RF: respiratory failure; MV: mechanic ventilator; and GI: gastrointestinal Data is shown as mean ± standard deviation. No statistic was computed because variable is a constant.
